• FirefoxInstall the new Firefox »
  •  Dow Down 0.75% Nasdaq Down 0.50%

    CTI BioPharma Corp. (CTIC)

    -NasdaqCM
    2.43 Up 0.01(0.41%) 10:58AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:2.42
    Open:2.44
    Bid:2.41 x 2100
    Ask:2.42 x 15100
    1y Target Est:5.08
    Beta:1.64
    Next Earnings Date:12-Mar-15CTIC Earnings announcement
    Day's Range:2.39 - 2.44
    52wk Range:2.00 - 4.22
    Volume:1,049,809
    Avg Vol (3m):1,798,380
    Market Cap:352.69M
    P/E (ttm):N/A
    EPS (ttm):-0.30
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CTIC

    Comparison

    Symbol% ChgMkt Cap
    CTICUp 0.41%352.69M
    BMYDown 0.23%102.69B
    RHHBYDown 0.67%N/A
    SNY 0.00%126.53B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):4.67
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.54
    Quarterly EPS Est (Dec-14) :-0.18
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    CTI BioPharma Corp., a biopharmaceutical company, is engaged in the acquisition, development, and commercialization of treatments for cancer. It primarily focuses on the commercialization of PIXUVRI, an aza-anthracenedione derivative, which is in ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback